These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9815176

  • 21. Synthesis and preliminary biological evaluation of (3-iodobenzoyl)norbiotinamide and ((5-iodo-3-pyridinyl)carbonyl)norbiotinamide: two radioiodinated biotin conjugates with improved stability.
    Foulon CF, Alston KL, Zalutsky MR.
    Bioconjug Chem; 1997; 8(2):179-86. PubMed ID: 9095358
    [Abstract] [Full Text] [Related]

  • 22. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
    Kobayashi H, Sun BF, Yoo TM, Le N, Kim MK, Paik CH, Pastan I, Waldmann TA, Carrasquillo JA.
    J Nucl Med; 1999 Aug; 40(8):1381-91. PubMed ID: 10450692
    [Abstract] [Full Text] [Related]

  • 23. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
    Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R.
    J Control Release; 2000 Mar 01; 65(1-2):133-48. PubMed ID: 10699277
    [Abstract] [Full Text] [Related]

  • 24. [In vivo expression of green fluorescent protein gene and immunogenicity of ES312 vaccine both mediated by starburst polyamidoamine dendrimers].
    Ding JJ, Guo CY, Cai QL, Lin YH, Wang H.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug 01; 27(4):499-503. PubMed ID: 16178448
    [Abstract] [Full Text] [Related]

  • 25. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.
    Wilbur DS, Hadley SW, Hylarides MD, Abrams PG, Beaumier PA, Morgan AC, Reno JM, Fritzberg AR.
    J Nucl Med; 1989 Feb 01; 30(2):216-26. PubMed ID: 2738650
    [Abstract] [Full Text] [Related]

  • 26. Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.
    Wilbur DS, Hamlin DK, Meyer DL, Mallett RW, Quinn J, Vessella RL, Press OW.
    Bioconjug Chem; 2002 Feb 01; 13(3):611-20. PubMed ID: 12009953
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
    Wakisaka K, Arano Y, Uezono T, Akizawa H, Ono M, Kawai K, Ohomomo Y, Nakayama M, Saji H.
    J Med Chem; 1997 Aug 01; 40(16):2643-52. PubMed ID: 9258371
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature.
    Muzykantov VR, Barnathan ES, Atochina EN, Kuo A, Danilov SM, Fisher AB.
    J Pharmacol Exp Ther; 1996 Nov 01; 279(2):1026-34. PubMed ID: 8930213
    [Abstract] [Full Text] [Related]

  • 32. HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein.
    Shi X, Bi X, Ganser TR, Hong S, Myc LA, Desai A, Holl MM, Baker JR.
    Analyst; 2006 Jul 01; 131(7):842-8. PubMed ID: 16802031
    [Abstract] [Full Text] [Related]

  • 33. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG, Oosterwijk E, Soede AC, Oyen WJ, McBride WJ, Griffiths GL, Goldenberg DM, Corstens FH, Boerman OC.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [Abstract] [Full Text] [Related]

  • 34. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
    Zhang XQ, Wang XL, Huang SW, Zhuo RX, Liu ZL, Mao HQ, Leong KW.
    Biomacromolecules; 2005 Sep 01; 6(1):341-50. PubMed ID: 15638538
    [Abstract] [Full Text] [Related]

  • 35. Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin.
    Kassis AI, Jones PL, Matalka KZ, Adelstein SJ.
    J Nucl Med; 1996 Feb 01; 37(2):343-52. PubMed ID: 8667075
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.
    Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, Kotlyar A, Baker JR.
    Bioconjug Chem; 2006 Feb 01; 17(5):1109-15. PubMed ID: 16984117
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs.
    Pisani MJ, Wheate NJ, Keene FR, Aldrich-Wright JR, Collins JG.
    J Inorg Biochem; 2009 Mar 01; 103(3):373-80. PubMed ID: 19121543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.